Roles of fluorescence in situ hybridization in differential diagnosis of urothelial carcinoma in upper urinary tract from benign diseases with hematuria

WANG Jian-dong,WU Jin-rong,CHENG Wen,WANG Xuan,SHI Shan-shan,ZHOU Xiao-Jun
DOI: https://doi.org/10.3969/j.issn.1001-7399.2012.10.006
2012-01-01
Abstract:Purpose To evaluate the clinical utility of a fluorescence in situ hybridization(FISH) assay as a non-invasively molecular test to distinguish urothelial carcinoma in upper urinary tract(UUT-UC) from benign lesions presenting with hematuria.Methods The chromosomal abnormalities of chromosomes 3,7,17,and 9(p16) in hematuria specimens from 34 patients with UUT-UC and 33 patients with benign disorders were detected by using a set of fluorescently labeled DNA probes.The abnormalities of chromosomes were determined and analyzed between UUT-UC and benign disorders.Results The abnormalities of chromosomes were detected in 25 out of 34(73.5%) patients with UUT UC and in 2 out of 33(6.1%) patients with benign disorders(P<0.001).Conclusions FISH assay of chromosomes 3,7,9,and 17 performed on exfoliated cells from voided urine specimens could be used as a non-invasive method to distinguish urothelial carcinoma in upper urinary tract from benign disorders presenting with hematuria.
What problem does this paper attempt to address?